- Home
- KRYS vs DOCN Comparison
KRYS vs DOCN Comparison
Compare KRYS & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- DOCN
- Stock Information
- Founded
- KRYS 2015
- DOCN 2011
- Country
- KRYS United States
- DOCN United States
- Employees
- KRYS N/A
- DOCN N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- DOCN Retail: Computer Software & Peripheral Equipment
- Sector
- KRYS Health Care
- DOCN Technology
- Exchange
- KRYS Nasdaq
- DOCN Nasdaq
- Market Cap
- KRYS 4.6B
- DOCN 3.7B
- IPO Year
- KRYS 2017
- DOCN 2021
- Fundamental
- Price
- KRYS $187.96
- DOCN $39.28
- Analyst Decision
- KRYS Strong Buy
- DOCN Buy
- Analyst Count
- KRYS 7
- DOCN 13
- Target Price
- KRYS $210.00
- DOCN $42.67
- AVG Volume (30 Days)
- KRYS 245.3K
- DOCN 1.3M
- Earning Date
- KRYS 02-19-2025
- DOCN 02-25-2025
- Dividend Yield
- KRYS N/A
- DOCN N/A
- EPS Growth
- KRYS 669.23
- DOCN N/A
- EPS
- KRYS 3.00
- DOCN 0.87
- Revenue
- KRYS $290,515,000.00
- DOCN $756,564,000.00
- Revenue This Year
- KRYS $483.09
- DOCN $14.26
- Revenue Next Year
- KRYS $57.70
- DOCN $13.04
- P/E Ratio
- KRYS $62.62
- DOCN $44.98
- Revenue Growth
- KRYS 473.02
- DOCN 12.08
- 52 Week Low
- KRYS $109.57
- DOCN $26.63
- 52 Week High
- KRYS $219.34
- DOCN $47.02
- Technical
- Relative Strength Index (RSI)
- KRYS 73.39
- DOCN 42.11
- Support Level
- KRYS $148.00
- DOCN $44.34
- Resistance Level
- KRYS $190.00
- DOCN $47.02
- Average True Range (ATR)
- KRYS 7.31
- DOCN 1.99
- MACD
- KRYS 3.66
- DOCN -0.49
- Stochastic Oscillator
- KRYS 93.87
- DOCN 7.47
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and Other countries.